Identifying Chandigarh’s potential

Express Pharma, a leading industry publication by The Indian Express Group, organised Chandigarh Pharma Summit 2022 on 8th July at Park Plaza, Zirakpur, under the theme ‘Sustaining and spearheading growth: Through pandemic and beyond.’

The summit’s key objective was to highlight the opportunities and benefits that this Union Territory (UT) and capital city offers to aid India’s ambitions to be a pharma powerhouse. Its proximity to other prominent pharma hubs like Baddi, Nalagarh, Paonta Sahib, Solan and Haryana, made it a perfect destination for industry stakeholders to come together and ponder upon issues that need much attention.

Leaders from the industry brainstormed and gave insights on strategies and measures needed to mitigate risks and challenges that prevent Chandigarh from achieving its true potential. They also reflected upon and discussed key issues that will help the industry to sustain its leadership position in a rapidly changing global milieu.

We bring you the excerpts of the addresses delivered by the eminent speakers during the summit:

• Special address: Dr Chandrashekar Ranga, Guest of Honour, Deputy Drugs Controller, India, Central Drugs Standard Control Organisation (CDSCO)
• Keynote address: Ripan Mehta, Assistant State Drugs Controller, Haryana, FDA
• Critical product solution for pharma industry: Upendra Singh Bisht, Manager—Business Development, Ami Polymer
• Advance active packaging solutions to prevent brittleness in capsules: Dhairy Sharma, Technical Sales, Cilicant
• Supply chain resilience: Dr Sanjit Singh Lamba, CEO, Valence Labs
• Measures to build a culture of quality and compliance in pharma industry: Dr Deo Narain Dikshit, Consultant,Pharma Quality, Compliance and Manufacturing process, Aqex Pharma Solutions
• Nitrosamine impurity analysis with LC-MS/MS: Dr Anoop Kumar, Head, Market Development and Marketing, SCIEX
• Aseptic BioProcess Equipment Manufacturer: NVS Vishal, Business Development Executive, Omega Scientific Instruments
• Impact of COVID-19 on pharma formulation: Bhupendra Pratap Singh Chauhan, CQA Head, Morepen Laboratories

Chandigarh industrial area is home to several pharma manufacturing companies such as Pfizer and Ind Swift. There are approximately 800 pharma companies in this UT, including two locations of tricity Panchkula and Mohali, as per a March 2022 IBEF report.

The state government of Chandigarh has been committed to create a progressive business environment. Besides, the National Industrial Corridor Development Corporation (NICDC) will develop the BaddiBarotiwala-Nalagarh (BBN) Node under the Amritsar-Kolkata Industrial Corridor Project to provide better ease of logistics for the industry, create jobs and aid economic growth. Express Pharma looks forward to this city’s growth as a major pharma hub in future.

akanki.sharma@expressindia.com
journoakanki@gmail.com